Inactive Instrument

Analyst Reco. WellPoint Inc Nyse

Equities

WLP

US94973V1070

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

Mizuho Adjusts Price Target on Elevance Health to $585 From $575	Apr. 24	MT
TD Cowen Adjusts Elevance Health's Price Target to $624 From $555	Apr. 23	MT
UBS Adjusts Price Target on Elevance Health to $605 From $585, Maintains Buy Rating	Apr. 19	MT
Bernstein Adjusts Price Target on Elevance Health to $665 From $629	Apr. 19	MT
Leerink Partners Adjusts Elevance Health Price Target to $630 From $565	Apr. 19	MT
Jefferies & Co Adjusts Elevance Health Price Target to $604 From $602	Apr. 19	MT
Goldman Sachs Raises Elevance Health's Price Target to $600 From $578	Apr. 19	MT
RBC Lifts Price Target on Elevance Health to $575 From $574, Cites 'Stronger Guidance,' Keeps Outperform Rating	Apr. 19	MT
Truist Lifts Price Target on Elevance Health to $600 From $580, Notes 'Solid' Q1, 2024 Guidance Boost, Keeps Buy Rating	Apr. 19	MT
Wells Fargo Adjusts Elevance Health's Price Target to $600 From $557, Maintains Overweight Rating	Apr. 19	MT
Barclays Adjusts Elevance Health's Price Target to $621 From $584, Maintains Overweight Rating	Apr. 19	MT
Cantor Fitzgerald Raises Elevance Health Price Target to $600 from $580	Apr. 18	MT
Stephens Adjusts Elevance Health's Price Target to $615 From $580	Apr. 18	MT
Elevance Health 1Q Revenue Rises, Membership Keeps Declining; Raises Guidance	Apr. 18	DJ
Zacks Investment Research Adjusts Price Target on Elevance Health to $523 From $537	Apr. 15	MT
Wells Fargo Cuts Price Target on Elevance Health to $557 From $561, Maintains Overweight Rating	Apr. 08	MT
Barclays Starts Elevance Health With Overweight Rating, $584 Price Target	Mar. 06	MT
Cantor Fitzgerald Adjusts Price Target on Elevance Health to $580 From $547, Maintains Overweight Rating	Feb. 14	MT
US proposes reimbursement rate for Medicare Advantage 2025 payments	Jan. 31	RE
RBC Raises Price Target on Elevance Health to $574 From $572 Amid 'Solid End to 2023,' Keeps Outperform Rating	Jan. 25	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. WellPoint Inc Nyse

Equities

WLP

US94973V1070

Analyst Reco.

Filters